Matches in SemOpenAlex for { <https://semopenalex.org/work/W2752776294> ?p ?o ?g. }
- W2752776294 endingPage "136" @default.
- W2752776294 startingPage "123" @default.
- W2752776294 abstract "Elongation factor, RNA polymerase II, 2 (ELL2) is an RNA Pol II elongation factor with functional properties similar to ELL that can interact with the prostate tumor suppressor EAF2. In the prostate, ELL2 is an androgen response gene that is upregulated in benign prostatic hyperplasia (BPH). We recently showed that ELL2 loss could enhance prostate cancer cell proliferation and migration, and that ELL2 gene expression was downregulated in high Gleason score prostate cancer specimens. Here, prostate-specific deletion of ELL2 in a mouse model revealed a potential role for ELL2 as a prostate tumor suppressor in vivoEll2-knockout mice exhibited prostatic defects including increased epithelial proliferation, vascularity and PIN lesions similar to the previously determined prostate phenotype in Eaf2-knockout mice. Microarray analysis of prostates from Ell2-knockout and wild-type mice on a C57BL/6J background at age 3 months and qPCR validation at 17 months of age revealed a number of differentially expressed genes associated with proliferation, cellular motility and epithelial and neural differentiation. OncoPrint analysis identified combined downregulation or deletion in prostate adenocarcinoma cases from the Cancer Genome Atlas (TCGA) data portal. These results suggest that ELL2 and its pathway genes likely play an important role in the development and progression of prostate cancer." @default.
- W2752776294 created "2017-09-15" @default.
- W2752776294 creator A5004781857 @default.
- W2752776294 creator A5006823760 @default.
- W2752776294 creator A5016322661 @default.
- W2752776294 creator A5017745501 @default.
- W2752776294 creator A5025664350 @default.
- W2752776294 creator A5037418007 @default.
- W2752776294 creator A5053875219 @default.
- W2752776294 creator A5056556589 @default.
- W2752776294 creator A5057209439 @default.
- W2752776294 creator A5059566534 @default.
- W2752776294 creator A5064478020 @default.
- W2752776294 creator A5074750436 @default.
- W2752776294 creator A5081963781 @default.
- W2752776294 creator A5082165277 @default.
- W2752776294 creator A5084151824 @default.
- W2752776294 creator A5091642808 @default.
- W2752776294 date "2017-11-01" @default.
- W2752776294 modified "2023-10-17" @default.
- W2752776294 title "Conditional deletion of ELL2 induces murine prostate intraepithelial neoplasia" @default.
- W2752776294 cites W1538757014 @default.
- W2752776294 cites W1763520601 @default.
- W2752776294 cites W187587110 @default.
- W2752776294 cites W1984901090 @default.
- W2752776294 cites W1988168821 @default.
- W2752776294 cites W1991560250 @default.
- W2752776294 cites W1994847090 @default.
- W2752776294 cites W1995143982 @default.
- W2752776294 cites W1997665238 @default.
- W2752776294 cites W1999672218 @default.
- W2752776294 cites W2004018275 @default.
- W2752776294 cites W2007435025 @default.
- W2752776294 cites W2007649253 @default.
- W2752776294 cites W2021755549 @default.
- W2752776294 cites W2032351323 @default.
- W2752776294 cites W2032729457 @default.
- W2752776294 cites W2037992174 @default.
- W2752776294 cites W2043210655 @default.
- W2752776294 cites W2046090066 @default.
- W2752776294 cites W2047178888 @default.
- W2752776294 cites W2050515820 @default.
- W2752776294 cites W2051025382 @default.
- W2752776294 cites W2063345200 @default.
- W2752776294 cites W2063738914 @default.
- W2752776294 cites W2065130184 @default.
- W2752776294 cites W2070636904 @default.
- W2752776294 cites W2072554910 @default.
- W2752776294 cites W2081963757 @default.
- W2752776294 cites W2084693374 @default.
- W2752776294 cites W2085893484 @default.
- W2752776294 cites W2087283266 @default.
- W2752776294 cites W2091885586 @default.
- W2752776294 cites W2096643907 @default.
- W2752776294 cites W2099054500 @default.
- W2752776294 cites W2105272438 @default.
- W2752776294 cites W2106876831 @default.
- W2752776294 cites W2107734506 @default.
- W2752776294 cites W2109496201 @default.
- W2752776294 cites W2114570899 @default.
- W2752776294 cites W2114843025 @default.
- W2752776294 cites W2117264216 @default.
- W2752776294 cites W2117932027 @default.
- W2752776294 cites W2122683221 @default.
- W2752776294 cites W2125920059 @default.
- W2752776294 cites W2125989214 @default.
- W2752776294 cites W2139876169 @default.
- W2752776294 cites W2141182368 @default.
- W2752776294 cites W2149441684 @default.
- W2752776294 cites W2152326114 @default.
- W2752776294 cites W2156215080 @default.
- W2752776294 cites W2170755007 @default.
- W2752776294 cites W2262087934 @default.
- W2752776294 cites W2326740299 @default.
- W2752776294 cites W2375818637 @default.
- W2752776294 cites W2584469982 @default.
- W2752776294 cites W4237014973 @default.
- W2752776294 doi "https://doi.org/10.1530/joe-17-0112" @default.
- W2752776294 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5679084" @default.
- W2752776294 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28870994" @default.
- W2752776294 hasPublicationYear "2017" @default.
- W2752776294 type Work @default.
- W2752776294 sameAs 2752776294 @default.
- W2752776294 citedByCount "12" @default.
- W2752776294 countsByYear W27527762942018 @default.
- W2752776294 countsByYear W27527762942019 @default.
- W2752776294 countsByYear W27527762942020 @default.
- W2752776294 countsByYear W27527762942022 @default.
- W2752776294 crossrefType "journal-article" @default.
- W2752776294 hasAuthorship W2752776294A5004781857 @default.
- W2752776294 hasAuthorship W2752776294A5006823760 @default.
- W2752776294 hasAuthorship W2752776294A5016322661 @default.
- W2752776294 hasAuthorship W2752776294A5017745501 @default.
- W2752776294 hasAuthorship W2752776294A5025664350 @default.
- W2752776294 hasAuthorship W2752776294A5037418007 @default.
- W2752776294 hasAuthorship W2752776294A5053875219 @default.
- W2752776294 hasAuthorship W2752776294A5056556589 @default.
- W2752776294 hasAuthorship W2752776294A5057209439 @default.